17 July 2012: Sysmex and DiaSys collaborate in the Clinical Chemistry business

Sysmex Asia Pacific Pte Ltd and DiaSys Diagnostic Systems GmbH have signed an agreement by which Sysmex will become DiaSys’s partner for distributing BioMajesty reagents in the Asia Pacific region… “Sysmex AP is delighted to enter into a distribution agreement with DiaSys in the Asia Pacific region. Pursuing our strategy of ‘Focus on Asia’, we […]

03 July 2012: Sysmex partners with Integrated Sciences for OSNA™ business in Australia

The OSNA™ BC System provides accurate intra-operative result for the detection of breast cancer metastasis in sentinel lymph node(s). The OSNA™ BC system has now been successfully marketed across Europe and Asia, adopted by 220 hospitals and has been reported in 17 publications since 2007. This highly sensitive and specific molecular-based system is helping to […]